AVALON GLOBOCARE CORP (ALBT)
US05344R2031 - Common Stock
Overall ALBT gets a fundamental rating of 0 out of 10. We evaluated ALBT against 65 industry peers in the Real Estate Management & Development industry. ALBT may be in some trouble as it scores bad on both profitability and health. ALBT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
ALBT had negative earnings in the past year.
In the past year ALBT has reported a negative cash flow from operations.
In the past 5 years ALBT always reported negative net income.
In the past 5 years ALBT always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of ALBT (-75.36%) is worse than 93.75% of its industry peers.
ALBT has a Return On Equity of -272.78%. This is amonst the worse of the industry: ALBT underperforms 82.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -75.36% | ||
| ROE | -272.78% | ||
| ROIC | N/A |
ROA(3y)-76.78%
ROA(5y)-104.98%
ROE(3y)-209.58%
ROE(5y)-268.15%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of ALBT (21.33%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALBT has declined.
The Profit Margin and Operating Margin are not available for ALBT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 21.33% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.44%
GM growth 5Y-5.37%
2. Health
2.1 Basic Checks
ALBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALBT has less shares outstanding
ALBT has less shares outstanding than it did 5 years ago.
ALBT has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -7.17, we must say that ALBT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -7.17, ALBT is not doing good in the industry: 92.19% of the companies in the same industry are doing better.
ALBT has a Debt/Equity ratio of 0.73. This is a neutral value indicating ALBT is somewhat dependend on debt financing.
ALBT's Debt to Equity ratio of 0.73 is in line compared to the rest of the industry. ALBT outperforms 42.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -7.17 |
ROIC/WACCN/A
WACC9.95%
2.3 Liquidity
ALBT has a Current Ratio of 0.11. This is a bad value and indicates that ALBT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.11, ALBT is doing worse than 92.19% of the companies in the same industry.
ALBT has a Quick Ratio of 0.11. This is a bad value and indicates that ALBT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALBT (0.11) is worse than 92.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 |
3. Growth
3.1 Past
The earnings per share for ALBT have decreased strongly by -2025.81% in the last year.
Looking at the last year, ALBT shows a small growth in Revenue. The Revenue has grown by 5.56% in the last year.
Measured over the past years, ALBT shows a decrease in Revenue. The Revenue has been decreasing by -4.25% on average per year.
EPS 1Y (TTM)-2025.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1197.48%
Revenue 1Y (TTM)5.56%
Revenue growth 3Y-3.1%
Revenue growth 5Y-4.25%
Sales Q2Q%4.59%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ALBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ALBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AVALON GLOBOCARE CORP
NASDAQ:ALBT (12/20/2024, 8:00:00 PM)
After market: 3.45 +0.03 (+0.88%)3.42
-0.47 (-12.08%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners1.59%
Inst Owner Change7.66%
Ins Owners35.31%
Ins Owner ChangeN/A
Market Cap3.73M
AnalystsN/A
Price TargetN/A
Short Float %4.46%
Short Ratio0.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.85 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.69 | ||
| P/tB | 0.69 | ||
| EV/EBITDA | N/A |
EPS(TTM)-19.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.3
FCFYN/A
OCF(TTM)-4.3
OCFYN/A
SpS1.2
BVpS4.96
TBVpS4.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -75.36% | ||
| ROE | -272.78% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 21.33% | ||
| FCFM | N/A |
ROA(3y)-76.78%
ROA(5y)-104.98%
ROE(3y)-209.58%
ROE(5y)-268.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.44%
GM growth 5Y-5.37%
F-Score4
Asset Turnover0.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.23% | ||
| Cap/Sales | 0.17% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 | ||
| Altman-Z | -7.17 |
F-Score4
WACC9.95%
ROIC/WACCN/A
Cap/Depr(3y)6.71%
Cap/Depr(5y)26.42%
Cap/Sales(3y)1.31%
Cap/Sales(5y)7.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2025.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1197.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.56%
Revenue growth 3Y-3.1%
Revenue growth 5Y-4.25%
Sales Q2Q%4.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y55.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.89%
OCF growth 3YN/A
OCF growth 5YN/A